Stephen Munn
Overview
Explore the profile of Stephen Munn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
124
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barreto S, Strasser S, McCaughan G, Fink M, Jones R, McCall J, et al.
Cancers (Basel)
. 2022 Jun;
14(11).
PMID: 35681757
Background: Expansion in liver transplantation (LT) criteria for HCC from Milan to UCSF has not adversely impacted overall survival, prompting further expansion towards Metroticket 2.0 (MT2). In this study, we...
2.
Howell J, Majumdar A, Fink M, Byrne M, McCaughan G, Strasser S, et al.
Liver Transpl
. 2021 Oct;
28(2):236-246.
PMID: 34624175
Introduction of universal access to direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) in Australia and New Zealand on March 1 , 2016, has had a major impact on...
3.
Jeffrey A, Delriviere L, McCaughan G, Crawford M, Angus P, Jones R, et al.
Transplant Direct
. 2019 Oct;
5(8):e472.
PMID: 31576368
Background: Liver retransplantation is technically challenging, and historical outcomes are significantly worse than for first transplantations. This study aimed to assess graft and patient survival in all Australian and New...
4.
Calzadilla-Bertot L, Jeffrey G, Jacques B, McCaughan G, Crawford M, Angus P, et al.
Liver Transpl
. 2019 Jan;
25(1):25-34.
PMID: 30609187
The worldwide increase in obesity and diabetes has led to predictions that nonalcoholic steatohepatitis (NASH) will become the leading indication for orthotopic liver transplantation (OLT). Data supporting this prediction from...
5.
6.
Wu L, Swan P, McCall J, Gane E, Holden A, Merrilees S, et al.
HPB (Oxford)
. 2018 May;
20(10):966-976.
PMID: 29843986
Background: potentially curative treatment options for hepatocellular carcinoma (HCC) include liver transplantation (LT), liver resection (LR) and thermal ablation (TA). Long term intent-to-treat (ITT) analysis from a single-centre using all...
7.
Arudchelvam J, Bartlett A, McCall J, Johnston P, Gane E, Munn S
ANZ J Surg
. 2015 Oct;
87(3):182-185.
PMID: 26471387
Background: Hepatic venous outflow obstruction (HVOO) is a rare but serious complication in liver transplantation (LT). Methods: We conducted a retrospective analysis of HVOO with venography and gradient measurement in...
8.
Verran D, Mulhearn M, Dilworth P, Balderson G, Munn S, Chen J, et al.
Med J Aust
. 2013 Nov;
199(9):610-2.
PMID: 24182227
Objectives: To examine whether incidence of colorectal malignancy is increased in Australasian liver transplant recipients compared with the general population of Australia, and to assess the characteristics and outcomes of...
9.
Matas A, Satel S, Munn S, Richards J, Tan-Alora A, Ambagtsheer F, et al.
Am J Transplant
. 2011 Dec;
12(2):306-12.
PMID: 22176925
Incentives for organ donation, currently prohibited in most countries, may increase donation and save lives. Discussion of incentives has focused on two areas: (1) whether or not there are ethical...
10.
Streat S, Munn S
Crit Care Clin
. 2011 Nov;
28(1):125-33, vii.
PMID: 22123104
Formal health economics and health technology assessment (HTA)processes, including cost-effectiveness and cost-utility analysis, are variably used to inform decisions about public and private health service funding and service provision. In...